• Please log in or register to access this feature.

Original Article

You have full text access to this OnlineOpen article

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome†

  1. Iris Cordoba MD1,
  2. José R. González-Porras MD1,‡,*,
  3. Benet Nomdedeu MD2,
  4. Elisa Luño MD3,
  5. Raquel de Paz MD4,
  6. Esperanza Such MD5,
  7. Mar Tormo MD6,
  8. Teresa Vallespi MD7,
  9. Rosa Collado MD8,
  10. Blanca Xicoy MD9,
  11. Rafael Andreu MD10,
  12. Juan A. Muñoz MD11,
  13. Francesc Solé MD12,
  14. Jose Cervera MD5,
  15. Consuelo del Cañizo MD1,
  16. On behalf of the Spanish Myelodysplastic Syndrome Registry1

Article first published online: 29 JUN 2011

DOI: 10.1002/cncr.26279

Issue

Cancer

Cancer

Volume 118, Issue 1, pages 127–133, 1 January 2012

Additional Information

How to Cite

Cordoba, I., González-Porras, J. R., Nomdedeu, B., Luño, E., de Paz, R., Such, E., Tormo, M., Vallespi, T., Collado, R., Xicoy, B., Andreu, R., Muñoz, J. A., Solé, F., Cervera, J., del Cañizo, C. and On behalf of the Spanish Myelodysplastic Syndrome Registry (2012), Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome. Cancer, 118: 127–133. doi: 10.1002/cncr.26279

Author Information

  1. 1

    Department of Hematology, Salamanca University Hospital, Salamanca, Spain

  2. 2

    Department of Hematology, Hospital Clinic, Barcelona, Spain

  3. 3

    Department of Hematology, Asturias University Hospital Center, Oviedo, Spain

  4. 4

    Department of Hematology, La Paz University Hospital, Madrid, Spain

  5. 5

    Department of Hematology, La Fe University Hospital, Valencia, Spain

  6. 6

    Department of Hematology, Valencia Hospital Clinic, Valencia, Spain

  7. 7

    Department of Hematology, Vall d'Hebron Hospital, Barcelona, Spain

  8. 8

    Department of Hematology, University General Hospital, Valencia, Spain

  9. 9

    Department of Hematology, Germans Trias i Pujol Hospital, Badalona, Spain

  10. 10

    Department of Hematology, Dr. Peset University Hospital, Valencia, Spain

  11. 11

    Department of Hematology, Puerta del Mar University Hospital, Cadiz, Spain

  12. 12

    Department of Hematology, Del Mar Hospital, Barcelona, Spain

  1. ‡

    Fax: (011) 34-923-292624

*Hospital Universitario de Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain

  1. †

    We thank V. Marco, S. Bonanad, L. Benlloch, D. Costa, J. Bueno, T. Bernal, and all members of the Spanish MDS Registry along with Phil Mason for their excellent technical assistance.

  2. ‡

    Fax: (011) 34-923-292624

Publication History

  1. Issue published online: 16 DEC 2011
  2. Article first published online: 29 JUN 2011
  3. Manuscript Revised: 21 APR 2011
  4. Manuscript Accepted: 21 APR 2011
  5. Manuscript Received: 15 MAR 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (292K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vera Ademà, Jesús María Hernández, María Abáigar, Eva Lumbreras, Esperanza Such, Anna Calull, Esther Dominguez, Leonor Arenillas, Mar Mallo, José Cervera, Isabel Marugán, Mar Tormo, Francisca García, Teresa González, Elisa Luño, Carmen Sanzo, María Luisa Martín, Manuela Fernández, Dolors Costa, Beatriz Blázquez, Beatriz Barreña, Fernando Marco, Ana Batlle, Ismael Buño, Carolina Martínez-Laperche, Víctor Noriega, Rosa Collado, David Ivars, Félix Carbonell, Isabel Vallcorba, Josefa Melero, Elena Delgado, María Teresa Vargas, Javier Grau, Marta Salido, Blanca Espinet, Carme Melero, Lourdes Florensa, Carmen Pedro, Francesc Solé, Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does −7/7q− detection by FISH have prognostic value?, Leukemia Research, 2013, 37, 4, 416

    CrossRef

  2. 2
    Paolo Bernasconi, Catherine Klersy, Marina Boni, Paola Maria Cavigliano, Irene Dambruoso, Rita Zappatore, Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution, American Journal of Hematology, 2013, 88, 2
    Direct Link:
  3. 3
    A. Jerez, Y. Sugimoto, H. Makishima, A. Verma, A. M. Jankowska, B. Przychodzen, V. Visconte, R. V. Tiu, C. L. O'Keefe, A. M. Mohamedali, A. G. Kulasekararaj, A. Pellagatti, K. McGraw, H. Muramatsu, A. R. Moliterno, M. A. Sekeres, M. A. McDevitt, S. Kojima, A. List, J. Boultwood, G. J. Mufti, J. P. Maciejewski, Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis, Blood, 2012, 119, 25, 6109

    CrossRef

  4. 4
    Fareeda Taher Nazer Hussain, Edward P. Nguyen, Sania Raza, Ryan Knudson, Animesh Pardanani, Curtis A. Hanson, Daniel Van Dyke, Ayalew Tefferi, Sole abnormalities of chromosome 7 in myeloid malignancies: Spectrum, histopathologic correlates, and prognostic implications, American Journal of Hematology, 2012, 87, 7
    Direct Link:
  5. 5
    Rafael Bejar, David P Steensma, Molecular Genetics of Myelodysplastic Syndromes, eLS,
    Direct Link:
View Full Article (HTML) Get PDF (292K)